We are positive, because the Prime Minister asked very necessary and meaningful questions - we went through all the issues, we provided information that our process is not politically driven, - Zakro Gvishiani, the parent of a child suffering from Duchenne muscular dystrophy, stated after a meeting with the Prime Minister.

According to him, the parties agreed that a working format will be created and, most likely, the meeting will be held again on June 5.

"We provided detailed information regarding medicines, current problems, and why it was necessary to hold continuous rallies in front of the Government Palace. We are positive, because the Prime Minister asked very necessary and meaningful questions. We exchanged information. We already see that Mr. Irakli Kobakhidze is ready to receive as much information as possible, and we agreed that a working group, a format, will be created. We will meet again the day after tomorrow and go through individual issues again, which was not possible today. We also provided information that our process is not politically driven. The main demand of the parents who are involved is to receive medicines. The solidarity that the society has expressed is not driven by anyone and is related to the needs that are necessary for children. We have not had any communication with pharmaceutical companies and it sounded very bad, as if some parent or organization was being driven by some pharmaceutical mafia. These questions were also answered. There are a number of medicines that are recognized both in Europe and America, and finally Great Britain recognized them. In this regard, information was exchanged and the necessary information was received," Gvishiani said.

According to him, today's meeting was also attended by the Minister of Health Mikheil Sarjveladze, and there was no talk at all about contraindications to medicines and fatal outcomes.

Gvishiani notes that today's meeting was promising and "the next meetings will be a concretization of the processes necessary to obtain medicines."